Neuralink has posted an update on the first three patients who received a Neuralink brain-computer interface (BCI) called the Link, which gives users almost “telepathic” abilities.

Now, three people have this technology: Noland, Alex, and Brad. They all can’t move their arms or legs because of different health issues. Noland and Alex have spinal cord injuries (SCI), which is damage to the spinal cord that stops movement. Brad has amyotrophic lateral sclerosis (ALS), a disease that slowly takes away control over muscles.

These three are part of Neuralink’s PRIME Study, which studies if the Link is safe and helpful. So far, they’ve used the Link for over 670 days and Telepathy for more than 4,900 hours. They use it during research sessions and on their own for daily tasks. Last month, they averaged 6.5 hours of independent use each day. As they get used to it, they use the Link more.

Improving and adapting BCI technology

Noland says the Link has let him reconnect with his world after a swimming accident left him paralyzed. Before, he used a mouth stick to control a tablet, which was tiring and limited. Now, he can browse the internet, play games, and learn with more freedom. He even did a 72-hour live stream on X, showing how he uses Telepathy.

Alex, who loved creating things before his accident, now uses CAD software and Adobe Illustrator for design work through Telepathy. He’s also learning to code Arduino projects. This technology has given him back his creative drive.

Brad, with late-stage ALS, couldn’t communicate easily outside or in bright light before. The Link lets him type on a computer screen, allowing him to interact with his family and community in various settings. He can now join his son at events and talk to neighbors, enhancing his quality of life significantly.

These pioneers are helping to expand what’s possible with BCI technology, offering hope and new capabilities to those with severe mobility issues. Their feedback is crucial for improving and adapting this technology for future users.

Neuralink has ongoing trials in the U.S. and Canada, and plans for the U.K.

Let us know your thoughts! Sign up for a Mindplex account now, join our Telegram, or follow us on Twitter.